• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sleep Number Announces Fourth Quarter and Full Year 2025 Results

    3/12/26 7:00:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary
    Get the next $SNBR alert in real time by email

    Reports FY2025 Net Sales of $1.4 Billion, Exceeding Adjusted EBITDA Guidance

    Realized $185 Million of Annualized Cost Savings

    Launches New Products as the Next Phase of Turnaround Strategy to Return to Profitable Growth

    Sleep Number Corporation (NASDAQ:SNBR) today reported results for fourth quarter and the year ended January 3, 2026.

    Linda Findley, President and CEO, commented, "Sleep Number exceeded 2025 guidance provided on our last earnings call. We are still in full turnaround mode and made significant progress against our new product and marketing strategies while continuing to reduce costs. For the full year 2025, pro-forma adjusted EBITDA margin was approximately 9% and anticipate double-digit adjusted EBITDA growth in 2026 as we continue to execute on our strategy.

    "The launch of our ComfortMode bed in January exceeded our expectations and is outselling plan by 3.5 times, with stronger margins than the beds it replaces. The rest of the new product line, available this month, is all built on the same consumer research highlighting comfort and value, and we anticipate similar strength from the new beds, as the supporting marketing is also performing well.

    "Even with the strength of our product and marketing strategies, the negative industry impact at the start of the year plus the clearance of our existing products had an outsized impact on our liquidity. We are implementing a plan to address our liquidity and capital strategy as we move towards topline growth in the second half of the year."

    Fourth Quarter Overview (all comparisons year-over-year unless otherwise noted)

    • Net sales of $347 million, down 8%, driven by ongoing industry demand pressure and lower store traffic.
    • Gross profit of $193 million, a decrease of $32 million. Gross profit margin of 55.6% compared to 59.9% for the same period last year, primarily due to a $9.6 million inventory obsolescence charge associated with the introduction of the company's new product line. Excluding the charge, adjusted gross profit margin was 58.4%.
    • Operating expenses were $201 million. Adjusted operating expenses before restructuring and other non-recurring costs were $197 million, a decrease of $20 million, or 9%, driven by lower marketing and selling expenses, general and administrative expenses, and research and development expenses.
    • Restructuring and other non-recurring costs were $14 million, driven primarily by the $9.6 million inventory obsolescence charge and contract termination costs due to store closures.
    • Net loss of $59 million compared with a net loss of $5 million for the same period last year, driven primarily by lower net sales and recognition of a $47.9 million deferred tax valuation adjustment during the fourth quarter of 2025.
    • Adjusted EBITDA of $19 million, down 26%, driven by a year-over-year net sales decline, partially offset by lower operating expenses. Adjusted EBITDA margin of 5.6%, down 140 basis points ("bps").

    Full Year Overview (all comparisons year-over-year unless otherwise noted)

    • Net sales of $1.4 billion, down 16%, driven by driven by ongoing industry pressure and lower store traffic.
    • Gross profit of $833 million, a decrease of $170 million. Gross profit margin of 59.0% of net sales, down 60 bps, driven by the $9.6 million inventory write-down charge and partially offset by the benefit of product cost reductions through value engineering and ongoing supplier negotiations and ongoing efficiencies in our home delivery and logistics operations.
    • Operating expenses were $880 million. Adjusted operating expenses before restructuring and other non-recurring costs were $824 million, a decrease of $136 million, or 14%, driven by lower marketing and selling expenses, general and administrative expenses, and research and development expenses.
    • Restructuring and other non-recurring costs were $65 million, driven primarily by severance and employee-related benefits, contract termination costs due to store closures, asset impairment charges, and inventory obsolescence.
    • Net loss of $132 million compared with a net loss of $20 million last year.
    • Adjusted EBITDA of $78 million, down 35%, driven by year-over year net sales decline, partially offset by lower operating expenses. Adjusted EBITDA margin of 5.5%, down 160 bps, exiting the year with an annualized pro forma adjusted EBITDA margin of approximately 9%, a 200 bps improvement versus the prior year.

    Cash Flows and Liquidity Review (all comparisons year-over-year unless otherwise noted)

    • Net cash used in operating activities was $3 million, down $30 million.
    • Free cash flow was a use of $18 million, down $21 million.
    • The company's leverage ratio calculated under its credit agreement was 4.1x EBITDAR at the end of the year versus the amended covenant maximum of 4.5x.

    Additional Business Highlights

    Sleep Number is executing a turnaround strategy centered on product, marketing and distribution with ongoing cost savings and operating efficiencies to reignite growth and increase financial resilience. Recent highlights include:

    • Leadership and Organizational Realignment – After appointing a new CEO in April 2025, the company further strengthened the executive team with the appointment of a new Chief Marketing Officer in May 2025 and Chief Financial Officer in December 2025 while reorganizing reporting lines and responsibilities to improve accountability, accelerate decision-making, and enhance customer responsiveness.
    • Product Portfolio Transformation – The company announced a new product line, taking only ten months versus the historical two years to design and develop, aimed to meet customer demands and simplify the shopping experience to address a broader range of sleep needs. Sleep Number launched the ComfortMode™ bed in January and sales have exceeded expectations by more than three times. The remainder of the new product line was announced separately today and will be available for purchase on March 23.
    • Modernized Marketing Foundation – Under new leadership, Sleep Number has rebuilt its marketing foundation with refreshed creative and channel-specific media strategies aimed at strengthening brand awareness and funnel performance to drive purchase intent.
    • Cost Structure Reset – Implemented $185 million of annualized cost reductions through efficiencies in general and administrative, corporate structure, technology, and adapting Sleep Number's existing real estate footprint. These changes created a more agile organization while preserving innovation. In 2026, Sleep Number is implementing another $50 million of annualized fixed costs savings.
    • Capital Structure Review – Engaged Guggenheim Securities to evaluate inbound interest and other opportunities to address the company's amended credit facility and improve Sleep Number's liquidity, balance sheet and flexibility.

    Conference Call Information

    Management will host its regularly scheduled conference call to discuss the company's results at 8:30 a.m. ET (7:30 a.m. CT; 5:30 a.m. PT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.

    About Sleep Number Corporation

    Sleep Number is the leader in personalized sleep wellness. Its mattresses are designed to evolve with each sleeper to help them feel and perform their best. With adjustable firmness, pressure-relieving support and temperature balancing comfort built into every mattress, Sleep Number® beds adapt to customers' changing needs, night after night, year after year.

    Backed by almost 40 years of innovation, 1,000+ patents and patents pending, and billions of hours of sleep data, Sleep Number has helped more than 16 million people achieve their best sleep. The fully integrated model ensures quality, durability, and care at every step—from design and craftsmanship to delivery and long-term support.

    Sleep Number products are awarded the industry's top recognitions, including ranked #1 in customer satisfaction for mattresses purchased in-store and online, and #1 in comfort, by J.D. Power. In addition, the company is the Official Sleep + Wellness Partner of the NFL, marking a relationship that leverages player health data, team partnerships, and league-wide initiatives to amplify brand awareness and drive consumer engagement.

    Sleep Number mattresses, bases, bedding, and furniture are available exclusively at its 600 stores nationwide and online. To learn more, visit SleepNumber.com or a store near you.

    Forward-looking Statements

    Statements used in this news release relating to future plans, events, financial results or performance, such as the statements that: the company is launching new products as the next phase of its turnaround strategy to return to profitable growth; it anticipates double digit increase to adjusted EBITDA in 2026; it anticipates strong sales and margins from the new product line launching this month; it is implementing a plan to address liquidity and capital strategy as it moves towards topline growth in the second half of 2026; it is executing a turnaround strategy centered on product, marketing and distribution with ongoing cost savings and operating efficiencies to reignite growth and increase financial resilience; it is implementing $50 million of annualized fixed costs savings in 2026; and it is working with Guggenheim Securities to address the company's amended credit facility and improve its liquidity, balance sheet and flexibility are forward-looking statements subject to certain risks and uncertainties which could cause the company's results to differ materially. The most important risks and uncertainties are described in the company's filings with the Securities and Exchange Commission, including in Item 1A of the company's Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.

    SLEEP NUMBER CORPORATION

    AND SUBSIDIARIES

    Consolidated Statements of Operations

    (unaudited – in thousands, except per share amounts)

     

     

    Fourteen Weeks Ended

     

     

     

    Thirteen Weeks Ended

     

     

     

    January 3,

    2026

     

    % of

    Net Sales

     

    December 28,

    2024

     

    % of

    Net Sales

    Net sales

    $

    347,385

     

     

    100.0

    %

     

    $

    376,817

     

     

    100.0

    %

    Cost of sales

     

    154,103

     

     

    44.4

    %

     

     

    151,236

     

     

    40.1

    %

    Gross profit

     

    193,282

     

     

    55.6

    %

     

     

    225,581

     

     

    59.9

    %

    Operating expenses:

     

     

     

     

     

     

     

    Sales and marketing

     

    161,238

     

     

    46.4

    %

     

     

    170,232

     

     

    45.2

    %

    General and administrative

     

    30,654

     

     

    8.8

    %

     

     

    38,234

     

     

    10.1

    %

    Research and development

     

    6,291

     

     

    1.8

    %

     

     

    10,653

     

     

    2.8

    %

    Restructuring costs

     

    3,151

     

     

    0.9

    %

     

     

    3,684

     

     

    1.0

    %

    Total operating expenses

     

    201,334

     

     

    58.0

    %

     

     

    222,803

     

     

    59.1

    %

    Operating (loss) income

     

    (8,052

    )

     

    (2.3

    %)

     

     

    2,778

     

     

    0.7

    %

    Interest expense, net

     

    13,880

     

     

    4.0

    %

     

     

    11,742

     

     

    3.1

    %

    Loss before income taxes

     

    (21,932

    )

     

    (6.3

    %)

     

     

    (8,964

    )

     

    (2.4

    %)

    Income tax expense (benefit)

     

    36,578

     

     

    10.5

    %

     

     

    (4,299

    )

     

    (1.1

    %)

    Net loss

    $

    (58,510

    )

     

    (16.8

    %)

     

    $

    (4,665

    )

     

    (1.2

    %)

     

     

     

     

     

     

     

     

    Net loss per share – basic and diluted

    $

    (2.55

    )

     

     

     

    $

    (0.21

    )

     

     

     

     

     

     

     

     

     

     

    Reconciliation of weighted-average shares outstanding:

    Basic weighted-average shares outstanding

     

    22,952

     

     

     

     

     

    22,659

     

     

     

    Dilutive effect of stock-based awards

     

    —

     

     

     

     

     

    —

     

     

     

    Diluted weighted-average shares outstanding

     

    22,952

     

     

     

     

     

    22,659

     

     

     

    For the fourteen weeks ended January 3, 2026 and the thirteen weeks ended December 28, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

    SLEEP NUMBER CORPORATION

    AND SUBSIDIARIES

    Consolidated Statements of Operations

    (unaudited – in thousands, except per share amounts)

     

     

    Fifty-Three Weeks Ended

     

     

     

    Fifty-Two Weeks Ended

     

     

     

    January 3,

    2026

     

    % of

    Net Sales

     

    December 28,

    2024

     

    % of

    Net Sales

    Net sales

    $

    1,411,450

     

     

    100.0

    %

     

    $

    1,682,296

     

     

    100.0

    %

    Cost of sales

     

    578,499

     

     

    41.0

    %

     

     

    679,523

     

     

    40.4

    %

    Gross profit

     

    832,951

     

     

    59.0

    %

     

     

    1,002,773

     

     

    59.6

    %

    Operating expenses:

     

     

     

     

     

     

     

    Sales and marketing

     

    664,235

     

     

    47.1

    %

     

     

    766,624

     

     

    45.6

    %

    General and administrative

     

    130,669

     

     

    9.3

    %

     

     

    149,956

     

     

    8.9

    %

    Research and development

     

    33,942

     

     

    2.4

    %

     

     

    45,255

     

     

    2.7

    %

    Restructuring costs

     

    50,697

     

     

    3.6

    %

     

     

    18,066

     

     

    1.1

    %

    Total operating expenses

     

    879,543

     

     

    62.3

    %

     

     

    979,901

     

     

    58.2

    %

    Operating (loss) income

     

    (46,592

    )

     

    (3.3

    %)

     

     

    22,872

     

     

    1.4

    %

    Interest expense, net

     

    49,382

     

     

    3.5

    %

     

     

    48,368

     

     

    2.9

    %

    Loss before income taxes

     

    (95,974

    )

     

    (6.8

    %)

     

     

    (25,496

    )

     

    (1.5

    %)

    Income tax expense (benefit)

     

    35,984

     

     

    2.5

    %

     

     

    (5,162

    )

     

    (0.3

    %)

    Net loss

    $

    (131,958

    )

     

    (9.3

    %)

     

    $

    (20,334

    )

     

    (1.2

    %)

     

     

     

     

     

     

     

     

    Net loss per share – basic and diluted

    $

    (5.77

    )

     

     

     

    $

    (0.90

    )

     

     

     

     

     

     

     

     

     

     

    Reconciliation of weighted-average shares outstanding:

    Basic weighted-average shares outstanding

     

    22,883

     

     

     

     

     

    22,606

     

     

     

    Dilutive effect of stock-based awards

     

    —

     

     

     

     

     

    —

     

     

     

    Diluted weighted-average shares outstanding

     

    22,883

     

     

     

     

     

    22,606

     

     

     

    For the fifty-three weeks ended January 3, 2026 and the fifty-two weeks ended December 28, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

    SLEEP NUMBER CORPORATION

    AND SUBSIDIARIES

    Consolidated Balance Sheets

    (unaudited – in thousands, except per share amounts)

    subject to reclassification

     

     

    January 3,

    2026

     

    December 28,

    2024

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    1,693

     

     

    $

    1,950

     

    Accounts receivable, net of allowances of $694 and $1,113, respectively

     

    15,502

     

     

     

    17,516

     

    Inventories

     

    82,233

     

     

     

    103,152

     

    Prepaid expenses

     

    13,656

     

     

     

    14,568

     

    Other current assets

     

    36,873

     

     

     

    44,098

     

    Total current assets

     

    149,957

     

     

     

    181,284

     

    Non-current assets:

     

     

     

    Property and equipment, net

     

    86,528

     

     

     

    129,574

     

    Operating lease right-of-use assets

     

    311,723

     

     

     

    356,641

     

    Goodwill and intangible assets, net

     

    66,186

     

     

     

    66,412

     

    Deferred income taxes

     

    399

     

     

     

    33,575

     

    Other non-current assets

     

    65,267

     

     

     

    93,324

     

    Total assets

    $

    680,060

     

     

    $

    860,810

     

    Liabilities and Shareholders' Deficit

     

     

     

    Current liabilities:

     

     

     

    Borrowings under revolving credit facility

    $

    588,200

     

     

    $

    546,600

     

    Accounts payable

     

    117,977

     

     

     

    107,619

     

    Customer prepayments

     

    39,527

     

     

     

    46,933

     

    Accrued sales returns

     

    12,817

     

     

     

    19,092

     

    Compensation and benefits

     

    14,975

     

     

     

    31,038

     

    Taxes and withholding

     

    11,429

     

     

     

    18,619

     

    Operating lease liabilities

     

    81,191

     

     

     

    82,307

     

    Other current liabilities

     

    46,430

     

     

     

    55,804

     

    Total current liabilities

     

    912,546

     

     

     

    908,012

     

    Non-current liabilities:

     

     

     

    Operating lease liabilities

     

    273,111

     

     

     

    307,201

     

    Other non-current liabilities

     

    72,878

     

     

     

    97,183

     

    Total non-current liabilities

     

    345,989

     

     

     

    404,384

     

    Total liabilities

     

    1,258,535

     

     

     

    1,312,396

     

    Shareholders' deficit:

     

     

     

    Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding

     

    —

     

     

     

    —

     

    Common stock, $0.01 par value; 142,500 shares authorized, 22,860 and 22,388 shares issued and outstanding, respectively

     

    229

     

     

     

    224

     

    Additional paid-in capital

     

    32,454

     

     

     

    27,390

     

    Accumulated deficit

     

    (611,158

    )

     

     

    (479,200

    )

    Total shareholders' deficit

     

    (578,475

    )

     

     

    (451,586

    )

    Total liabilities and shareholders' deficit

    $

    680,060

     

     

    $

    860,810

     

    SLEEP NUMBER CORPORATION

    AND SUBSIDIARIES

    Consolidated Statements of Cash Flows

    (unaudited – in thousands)

    subject to reclassification

     

     

    Fifty-Three Weeks Ended

     

    Fifty-Two Weeks Ended

     

    January 3,

    2026

     

    December 28,

    2024

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (131,958

    )

     

    $

    (20,334

    )

    Adjustments to reconcile net loss to net cash (used in) provided by

    operating activities:

     

     

     

    Depreciation and amortization

     

    55,608

     

     

     

    66,351

     

    Stock-based compensation

     

    6,282

     

     

     

    11,444

     

    Inventory obsolescence write off

     

    9,565

     

     

     

    —

     

    Loss on impairment of strategic investment asset

     

    16,225

     

     

     

    —

     

    Loss on disposal and impairment of leased assets

     

    20,319

     

     

     

    4,315

     

    Deferred income taxes

     

    33,176

     

     

     

    (13,322

    )

    Changes in operating assets and liabilities:

     

     

     

    Accounts receivable

     

    2,014

     

     

     

    9,343

     

    Inventories

     

    11,354

     

     

     

    12,281

     

    Income taxes

     

    (4,378

    )

     

     

    3,987

     

    Prepaid expenses and other assets

     

    9,889

     

     

     

    (10,867

    )

    Accounts payable

     

    22,673

     

     

     

    (15,910

    )

    Customer prepayments

     

    (7,406

    )

     

     

    (2,210

    )

    Accrued compensation and benefits

     

    (16,113

    )

     

     

    2,755

     

    Other taxes and withholding

     

    (2,812

    )

     

     

    (2,502

    )

    Other accruals and liabilities

     

    (27,721

    )

     

     

    (18,188

    )

    Net cash (used in) provided by operating activities

     

    (3,283

    )

     

     

    27,143

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

    Purchases of property and equipment

     

    (14,407

    )

     

     

    (23,505

    )

    Proceeds from sales of property and equipment

     

    —

     

     

     

    156

     

    Issuance of notes receivable

     

    —

     

     

     

    (2,942

    )

    Payment to secure contractual rights

     

    (3,280

    )

     

     

    —

     

    Net cash used in investing activities

     

    (17,687

    )

     

     

    (26,291

    )

     

     

     

     

    Cash flows from financing activities:

     

     

     

    Net increase (decrease) in short-term borrowings

     

    28,068

     

     

     

    (673

    )

    Repurchases of common stock

     

    (1,213

    )

     

     

    (768

    )

    Debt issuance costs

     

    (6,142

    )

     

     

    —

     

    Net cash provided by (used in) financing activities

     

    20,713

     

     

     

    (1,441

    )

     

     

     

     

    Net decrease in cash and cash equivalents

     

    (257

    )

     

     

    (589

    )

    Cash and cash equivalents, at beginning of period

     

    1,950

     

     

     

    2,539

     

    Cash and cash equivalents, at end of period

    $

    1,693

     

     

    $

    1,950

     

    SLEEP NUMBER CORPORATION

    AND SUBSIDIARIES

    Supplemental Financial Information

    (unaudited)

     

     

    Fourteen Weeks Ended

     

    Thirteen Weeks Ended

     

    Fifty-Three Weeks Ended

     

    Fifty-Two Weeks Ended

     

    January 3,

    2026

     

    December 28,

    2024

     

    January 3,

    2026

     

    December 28,

    2024

    Percent of sales:

     

     

     

     

     

     

     

    Retail stores

     

    86.6

    %

     

     

    86.6

    %

     

     

    87.6

    %

     

     

    87.6

    %

    Online, phone, chat and other

     

    13.4

    %

     

     

    13.4

    %

     

     

    12.4

    %

     

     

    12.4

    %

    Total Company

     

    100.0

    %

     

     

    100.0

    %

     

     

    100.0

    %

     

     

    100.0

    %

     

     

     

     

     

     

     

     

    Sales change rates:

     

     

     

     

     

     

     

    Retail comparable-store sales4

     

    (15

    %)

     

     

    (9

    %)

     

     

    (17

    %)

     

     

    (9

    %)

    Online, phone and chat4

     

    (15

    %)

     

     

    (17

    %)

     

     

    (17

    %)

     

     

    (17

    %)

    Total Retail comparable sales change4

     

    (15

    %)

     

     

    (10

    %)

     

     

    (17

    %)

     

     

    (10

    %)

    Net opened/closed stores and other

     

    7

    %

     

     

    (2

    %)

     

     

    1

    %

     

     

    (1

    %)

    Total Company

     

    (8

    %)

     

     

    (12

    %)

     

     

    (16

    %)

     

     

    (11

    %)

     

     

     

     

     

     

     

     

    Stores open:

     

     

     

     

     

     

     

    Beginning of period

     

    611

     

     

     

    643

     

     

     

    640

     

     

     

    672

     

    Opened

     

    1

     

     

     

    1

     

     

     

    6

     

     

     

    12

     

    Closed

     

    (12

    )

     

     

    (4

    )

     

     

    (46

    )

     

     

    (44

    )

    End of period

     

    600

     

     

     

    640

     

     

     

    600

     

     

     

    640

     

     

     

     

     

     

     

     

     

    Other metrics:

     

     

     

     

     

     

     

    Average sales per store ($ in 000's)1,4

    $

    1,946

     

     

    $

    2,601

     

     

     

     

     

    Average sales per square foot1,4

    $

    629

     

     

    $

    841

     

     

     

     

     

    Stores > $2 million net sales2,4

     

    32

    %

     

     

    57

    %

     

     

     

     

    Stores > $3 million net sales2,4

     

    8

    %

     

     

    18

    %

     

     

     

     

    Average revenue per smart bed unit3

    $

    6,393

     

     

    $

    5,959

     

     

    $

    6,060

     

     

    $

    5,818

     

    1

    Trailing twelve months Total Retail comparable sales per store open at least one year.

    2

    Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).

    3

    Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.

    4

    Fiscal 2025 included 53 weeks, as compared to 52 weeks in fiscal 2024. The additional week in 2025 was in the fiscal fourth quarter. Total Retail comparable sales have been adjusted to remove the estimated impact of the additional week on the three and twelve months ended January 3, 2026.

    SLEEP NUMBER CORPORATION AND SUBSIDIARIES

    Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)

    (in thousands)

    We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net loss plus: income tax expense (benefit), interest expense, depreciation and amortization, stock-based compensation, restructuring costs, other non-recurring items, and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

     

    Three Months Ended

     

    Trailing Twelve Months Ended

     

    January 3,

    2026

     

    December 28,

    2024

     

    January 3,

    2026

     

    December 28,

    2024

    Net loss

    $

    (58,510

    )

     

    $

    (4,665

    )

     

    $

    (131,958

    )

     

    $

    (20,334

    )

    Income tax expense (benefit)

     

    36,578

     

     

     

    (4,299

    )

     

     

    35,984

     

     

     

    (5,162

    )

    Interest expense

     

    13,880

     

     

     

    11,742

     

     

     

    49,382

     

     

     

    48,368

     

    Depreciation and amortization

     

    12,091

     

     

     

    15,628

     

     

     

    53,169

     

     

     

    64,979

     

    Stock-based compensation

     

    1,570

     

     

     

    1,903

     

     

     

    6,282

     

     

     

    11,444

     

    Restructuring costs1

     

    3,151

     

     

     

    3,684

     

     

     

    50,697

     

     

     

    18,066

     

    Other non-recurring items2

     

    10,643

     

     

     

    998

     

     

     

    14,699

     

     

     

    998

     

    Asset impairments

     

    —

     

     

     

    1,220

     

     

     

    —

     

     

     

    1,220

     

    Adjusted EBITDA

    $

    19,403

     

     

    $

    26,211

     

     

    $

    78,255

     

     

    $

    119,579

     

    1

    Represents costs related to business restructuring actions.

    2

    Other non-recurring items includes the following:

     

    Three Months Ended

     

    Trailing Twelve Months Ended

     

    January 3,

    2026

     

    December 28,

    2024

     

    January 3,

    2026

     

    December 28,

    2024

    Inventory obsolescence write off

    $

    9,565

     

    $

    —

     

    $

    9,565

     

    $

    —

    CEO transition costs

     

    450

     

     

    224

     

     

    1,584

     

     

    224

    Debt issuance cost write off

     

    —

     

     

    —

     

     

    1,596

     

     

    —

    Proxy contest costs

     

    —

     

     

    774

     

     

    1,148

     

     

    774

    CFO search costs

     

    164

     

     

    —

     

     

    340

     

     

    —

    Legal and consulting costs

     

    464

     

     

    —

     

     

    466

     

     

    Other non-recurring items

    $

    10,643

     

    $

    998

     

    $

    14,699

     

    $

    998

    Free Cash Flow

    (in thousands)

     

     

    Three Months Ended

     

    Trailing Twelve Months Ended

     

    January 3,

    2026

     

    December 28,

    2024

     

    January 3,

    2026

     

    December 28,

    2024

    Net cash provided by (used in) operating activities

    $

    1,876

     

     

    $

    (23,681

    )

     

    $

    (3,283

    )

     

    $

    27,143

    Subtract: Purchases of property and equipment

     

    2,519

     

     

     

    6,287

     

     

     

    14,407

     

     

     

    23,505

    Free cash flow

    $

    (643

    )

     

    $

    (29,968

    )

     

    $

    (17,690

    )

     

    $

    3,638

    Note - Our Adjusted EBITDA and Free Cash Flow are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

    GAAP - generally accepted accounting principles in the U.S.

    SLEEP NUMBER CORPORATION AND SUBSIDIARIES

    Reconciliation of GAAP to Non-GAAP Financial Measures

    (in thousands)

     

     

    Three Months Ended

     

    Trailing Twelve Months Ended

     

    January 3,

    2026

     

    December 28,

    2024

     

    January 3,

    2026

     

    December 28,

    2024

    Operating expenses

    $

    201,334

     

    $

    222,803

     

    $

    879,543

     

    $

    979,901

    Subtract: Restructuring costs

     

    3,151

     

     

    3,684

     

     

    50,697

     

     

    18,066

    Subtract: Asset impairments

     

    —

     

     

    1,220

     

     

    —

     

     

    1,220

    Subtract: Other non-recurring items1

     

    1,078

     

     

    998

     

     

    5,134

     

     

    998

    Non-GAAP operating expenses

    $

    197,105

     

    $

    216,901

     

    $

    823,712

     

    $

    959,617

    Operating expense reduction versus prior period, excluding restructuring costs and non-recurring items

    $

    19,796

     

     

     

    $

    135,905

     

     

    1

    Excludes inventory obsolescence write off of $9.6 million, which is included in the cost of sales line on the statement of operations.

     

    Three Months Ended

     

    Trailing Twelve Months Ended

     

    January 3,

    2026

     

    December 28,

    2024

     

    January 3,

    2026

     

    December 28,

    2024

    Gross profit

    $

    193,282

     

     

    $

    225,581

     

     

    $

    832,951

     

     

    $

    1,002,773

     

    Gross profit margin

     

    55.6

    %

     

     

    59.9

    %

     

     

    59.0

    %

     

     

    59.6

    %

    Add: Inventory obsolescence write off

     

    9,565

     

     

     

    —

     

     

     

    9,565

     

     

     

    —

     

    Non-GAAP gross profit

    $

    202,847

     

     

    $

    225,581

     

     

    $

    842,516

     

     

    $

    1,002,773

     

    Non-GAAP gross profit margin

     

    58.4

    %

     

     

    59.9

    %

     

     

    59.7

    %

     

     

    59.6

    %

     

    Trailing Twelve Months Ended

     

    January 3,

    2026

    Adjusted EBITDA

    $

    78,255

     

    Proforma annualized cost reductions1

     

    50,000

     

    Proforma adjusted EBITDA

     

    128,255

     

    Net sales

     

    1,411,450

     

    Proforma adjusted EBITDA margin

     

    9.1

    %

    1

    Represents annualized impact of cost reductions over the future trailing twelve months the Company has executed.

     

     

    Note - Our Non-GAAP Operating Expenses, Non-GAAP Gross Profit, Non-GAAP Gross Profit Margin, and Proforma Adjusted EBITDA measures are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

    GAAP - generally accepted accounting principles in the U.S.

    SLEEP NUMBER CORPORATION AND SUBSIDIARIES

    Calculation of Net Leverage Ratio under Revolving Credit Facility

    (in thousands)

     

     

    Trailing Twelve Months Ended

     

    January 3,

    2026

     

    December 28,

    2024

    Borrowings under revolving credit facility

    $

    588,200

     

    $

    546,600

    Outstanding letters of credit

     

    8,800

     

     

    7,147

    Finance lease obligations

     

    159

     

     

    241

    Consolidated funded indebtedness

    $

    597,159

     

    $

    553,988

    Operating lease liabilities1

     

    354,302

     

     

    389,508

    Total debt including operating lease liabilities (a)

    $

    951,461

     

    $

    943,496

     

     

     

     

    Adjusted EBITDA (see above)

    $

    78,255

     

    $

    119,579

    Consolidated rent expense

     

    104,983

     

     

    107,105

    Proforma annualized cost reductions2

     

    50,000

     

     

    —

    Consolidated EBITDAR (b)

    $

    233,238

     

    $

    226,684

    Net Leverage Ratio under revolving credit facility (a divided by b)

    4.1 to 1.0

     

    4.2 to 1.0

    1

    Reflects operating lease liabilities included in our financial statements under ASC 842.

    2

    Represents annualized impact of cost reductions over the future trailing twelve months the Company has executed.

     

    Note - Our Net Leverage Ratio under Revolving Credit Facility, Adjusted EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

    GAAP - generally accepted accounting principles in the U.S.

    SLEEP NUMBER CORPORATION AND SUBSIDIARIES

    Calculation of Return on Invested Capital (Adjusted ROIC)

    (in thousands)

    Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:

     

    Trailing Twelve Months Ended

     

    January 3,

    2026

     

    December 28,

    2024

    Adjusted net operating profit after taxes (Adjusted NOPAT)

     

     

     

    Operating income

    $

    (46,592

    )

     

    $

    22,872

     

    Add: Operating lease interest1

     

    24,346

     

     

     

    26,775

     

    Less: Income taxes2

     

    4,495

     

     

     

    (11,907

    )

    Adjusted NOPAT

    $

    (17,751

    )

     

    $

    37,740

     

     

     

     

     

    Average adjusted invested capital

     

     

     

    Total deficit

    $

    (578,475

    )

     

    $

    (451,586

    )

    Add: Long-term debt3

     

    588,359

     

     

     

    546,841

     

    Add: Operating lease liabilities4

     

    354,302

     

     

     

    389,508

     

    Total adjusted invested capital at end of period

    $

    364,186

     

     

    $

    484,763

     

     

     

     

     

    Average adjusted invested capital5

    $

    439,902

     

     

    $

    497,972

     

     

     

     

     

    Adjusted ROIC6

     

    (4.0

    %)

     

     

    7.6

    %

    1

    Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.

    2

    Reflects annual effective income tax rates, before discrete adjustments, of 20.2% and 24.0% for January 3, 2026 and December 28, 2024, respectively.

    3

    Long-term debt includes existing finance lease liabilities.

    4

    Reflects operating lease liabilities included in our financial statements under ASC 842.

    5

    Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.

    6

    Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.

     

     

    Note - The Company's Adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

    GAAP - generally accepted accounting principles in the U.S.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260311968405/en/

    Investor Contact: [email protected]

    Media Contact: Muriel Lussier, [email protected]

    Get the next $SNBR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNBR

    DatePrice TargetRatingAnalyst
    4/21/2022$62.00 → $49.00Overweight → Neutral
    Piper Sandler
    3/28/2022$80.00 → $54.00Outperform → Neutral
    Wedbush
    2/24/2022$80.00 → $65.00Neutral
    UBS
    2/4/2022$85.00 → $88.00Neutral → Outperform
    Wedbush
    More analyst ratings

    $SNBR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sleep Number Redesigns Its Mattress Portfolio with Five Innovative New Beds That Adapt Night After Night as Customers' Needs Change

    Simplified Lineup Delivers Enhanced Comfort, Adjustability, Temperature Benefits and Value Across Three Collections: ComfortMode™, ComfortNext™ and Climate™ Sleep Number Corporation (NASDAQ:SNBR) today announced its largest product reset in almost a decade with the introduction of new, innovative beds designed to deliver a luxury experience at a more approachable price point. Available on March 23 online and in Sleep Number® stores, the five new beds offer superior comfort, personalized adjustability, temperature benefits and value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311848805/en/Sleep Number announced a redesig

    3/12/26 7:05:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number Announces Fourth Quarter and Full Year 2025 Results

    Reports FY2025 Net Sales of $1.4 Billion, Exceeding Adjusted EBITDA Guidance Realized $185 Million of Annualized Cost Savings Launches New Products as the Next Phase of Turnaround Strategy to Return to Profitable Growth Sleep Number Corporation (NASDAQ:SNBR) today reported results for fourth quarter and the year ended January 3, 2026. Linda Findley, President and CEO, commented, "Sleep Number exceeded 2025 guidance provided on our last earnings call. We are still in full turnaround mode and made significant progress against our new product and marketing strategies while continuing to reduce costs. For the full year 2025, pro-forma adjusted EBITDA margin was approximately 9% and anti

    3/12/26 7:00:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number Corporation to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026

    Sleep Number Corporation (NASDAQ:SNBR) will release its fiscal fourth quarter and full year results through January 3, 2026, before market open on Thursday, March 12, 2026. Management will host its regularly scheduled conference call to discuss the company's results at 8:30 a.m. EDT (7:30 a.m. CDT; 5:30 a.m. PDT). To access the webcast, please visit the investor relations area of the Sleep Number website at ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. About Sleep Number Corporation Sleep Number® is the leader in personalized sleep wellness. Its mattresses are designed to evolve with each sleeper to help them feel and perform their best. With

    3/3/26 4:34:00 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $SNBR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim CFO Ryder Robert P bought $102,160 worth of shares (15,000 units at $6.81) (SEC Form 4)

    4 - Sleep Number Corp (0000827187) (Issuer)

    8/4/25 4:05:05 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Director Eyler Phillip bought $74,942 worth of shares (8,300 units at $9.03), increasing direct ownership by 65% to 20,972 units (SEC Form 4)

    4 - Sleep Number Corp (0000827187) (Issuer)

    5/14/25 4:01:01 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    EVP & CFO Lee Francis K bought $51,263 worth of shares (7,200 units at $7.12), increasing direct ownership by 8% to 92,970 units (SEC Form 4)

    4 - Sleep Number Corp (0000827187) (Issuer)

    5/9/25 8:51:39 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $SNBR
    SEC Filings

    View All

    SEC Form 10-K filed by Sleep Number Corporation

    10-K - Sleep Number Corp (0000827187) (Filer)

    3/12/26 7:06:27 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Sleep Number Corp (0000827187) (Filer)

    3/12/26 7:03:24 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Sleep Number Corp (0000827187) (Filer)

    3/12/26 7:02:48 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $SNBR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP & Chief Financial Officer O'Keefe Amy K was granted 69,742 shares (SEC Form 4)

    4 - Sleep Number Corp (0000827187) (Issuer)

    12/15/25 4:04:21 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    New insider O'Keefe Amy K claimed no ownership of stock in the company (SEC Form 3)

    3 - Sleep Number Corp (0000827187) (Issuer)

    12/8/25 5:46:02 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    SEC Form 4 filed by SVP, Chief Supply Chain Skogerboe Tanya C.

    4 - Sleep Number Corp (0000827187) (Issuer)

    11/17/25 2:57:07 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $SNBR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sleep Number downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Sleep Number from Overweight to Neutral and set a new price target of $49.00 from $62.00 previously

    4/21/22 7:58:24 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number downgraded by Wedbush with a new price target

    Wedbush downgraded Sleep Number from Outperform to Neutral and set a new price target of $54.00 from $80.00 previously

    3/28/22 8:40:12 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    UBS reiterated coverage on Sleep Number with a new price target

    UBS reiterated coverage of Sleep Number with a rating of Neutral and set a new price target of $65.00 from $80.00 previously

    2/24/22 8:43:12 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $SNBR
    Leadership Updates

    Live Leadership Updates

    View All

    Sleep Number Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    Sleep Number Corporation (NASDAQ:SNBR) today announced that it granted an equity award on December 15, 2025, as a material inducement to the employment of the company's newly-hired Executive Vice President and Chief Financial Officer, Amy O'Keefe. As previously disclosed, in connection with the appointment of O'Keefe as Executive Vice President and Chief Financial Officer effective December 8, 2025, Sleep Number granted O'Keefe an employment inducement award consisting of 69,742 shares in a time-vested restricted stock unit award that vests in three equal installments on each anniversary from the date of grant. The grants are subject to continued employment and the terms of the award agree

    12/15/25 4:01:00 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number Names Amy O'Keefe as CFO

    O'Keefe Brings Proven Expertise in Driving Profitability and Cash Flow in Public and Private Companies Company Reaffirms Full Year 2025 Financial Guidance Sleep Number Corporation (NASDAQ:SNBR) today announces Amy O'Keefe as its next Chief Financial Officer (CFO), effective December 8, 2025. Interim CFO Bob Ryder will remain with the company to ensure a smooth transition through December 12, 2025. "Since joining Sleep Number, we've taken decisive action to stabilize the business and position it for sustainable growth. Our strategy is clear and centered on our strong brand, differentiated products, and simplified operating model to deliver value for shareholders, customers, and team membe

    12/2/25 7:30:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    Sleep Number Corporation (NASDAQ:SNBR) today announced that it granted equity awards on May 15, 2025, as a material inducement to the employment of the company's newly-hired Executive Vice President and Chief Marketing Officer, Amber Minson. In connection with the appointment of Minson as Executive Vice President and Chief Marketing Officer effective May 5, 2025, Sleep Number granted Minson employment inducement awards consisting of: (i) 21,724 shares in a performance stock unit award vesting on the third anniversary of the date of grant with the number of shares to be earned based on actual company performance for fiscal years 2025 to 2027 and the company's relative total shareholder retu

    5/16/25 9:01:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $SNBR
    Financials

    Live finance-specific insights

    View All

    Sleep Number Announces Fourth Quarter and Full Year 2025 Results

    Reports FY2025 Net Sales of $1.4 Billion, Exceeding Adjusted EBITDA Guidance Realized $185 Million of Annualized Cost Savings Launches New Products as the Next Phase of Turnaround Strategy to Return to Profitable Growth Sleep Number Corporation (NASDAQ:SNBR) today reported results for fourth quarter and the year ended January 3, 2026. Linda Findley, President and CEO, commented, "Sleep Number exceeded 2025 guidance provided on our last earnings call. We are still in full turnaround mode and made significant progress against our new product and marketing strategies while continuing to reduce costs. For the full year 2025, pro-forma adjusted EBITDA margin was approximately 9% and anti

    3/12/26 7:00:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number Corporation to Announce Fourth Quarter and Full Year 2025 Results on March 12, 2026

    Sleep Number Corporation (NASDAQ:SNBR) will release its fiscal fourth quarter and full year results through January 3, 2026, before market open on Thursday, March 12, 2026. Management will host its regularly scheduled conference call to discuss the company's results at 8:30 a.m. EDT (7:30 a.m. CDT; 5:30 a.m. PDT). To access the webcast, please visit the investor relations area of the Sleep Number website at ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days. About Sleep Number Corporation Sleep Number® is the leader in personalized sleep wellness. Its mattresses are designed to evolve with each sleeper to help them feel and perform their best. With

    3/3/26 4:34:00 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Sleep Number Announces Third Quarter 2025 Results

    Company Secured an Amendment and Extension of Bank Agreement Through 2027 Sleep Number Executing a Company-wide Turnaround to Reposition Brand, Expand Reach, and Reignite Growth Reported net sales of $343 million, down 19.6% compared with the third quarter of 2024 Delivered gross profit margin of 59.9%, compared to 60.8% for the same period last year Reduced third quarter operating expenses by $44.8 million, or 18%, year-over-year, before restructuring and other non-recurring costs. Reported net loss of $40 million, compared to a net loss of $3 million for the same period last year Delivered adjusted EBITDA of $13 million, down $14 million versus the same period last year Amend

    11/5/25 7:00:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $SNBR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Sleep Number Corporation

    SC 13D/A - Sleep Number Corp (0000827187) (Subject)

    12/2/24 5:07:30 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Sleep Number Corporation

    SC 13D/A - Sleep Number Corp (0000827187) (Subject)

    11/25/24 6:54:27 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Sleep Number Corporation

    SC 13D/A - Sleep Number Corp (0000827187) (Subject)

    11/4/24 7:08:50 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary